Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 13Gastrointestinal 7Tumor-Agnostic 6Thoracic 6Genitourinary 6Gynecologic 5Other hematologic neoplasm 3Head & Neck 3CNS 3Lymphoid 2Dermatologic 2Plasma cell 1Other 1

Conditions

Hematologic Neoplasms 2Lymphoma 1Leukemia 1Depression 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 265Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Focus Groups × Other hematologic neoplasm × Clear all
NCT05012124 2026-04-16

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

University of Washington

Phase NA Terminated
297 enrolled
Other hematologic neoplasm

Depression, Hematologic Neoplasms

NCT01608152 2025-10-27

Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

M.D. Anderson Cancer Center

Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT04694911 2025-04-29

Development of the Oncology Opportunity Cost Assessment Tool

Thomas Jefferson University

Completed
40 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡